The Societal Impact Of Natalizumab Treatment In The Italian Relapsing-Remitting Multiple Sclerosis Clinical Practi The Tysabri® Pharmacoeconomics (Type) Study
Abstract
Authors
B Polistena F Spandonaro C Gasperini GB Zimatore L Santoni S Fantaccini R Capra